昊海生物科技拟使用暂时闲置募集资金进行现金管理

Core Viewpoint - Haohai Biological Technology (06826) announced plans to enhance the efficiency of raised funds by utilizing a portion of temporarily idle funds for cash management, aiming to increase company income and shareholder returns [1] Fund Utilization - The company plans to use no more than RMB 300 million (including the principal) of temporarily idle raised funds for cash management [1] - The usage period for these funds is effective for 12 months from the date of board approval [1] - Within the specified limit and timeframe, the funds can be used in a rolling manner [1]